Diuretic Drugs Market to Record a CAGR of 5.44%, Increasing Incidence of Hypertension Among People to Drive Growth - Technavio
NEW YORK, Sept. 29, 2022 /PRNewswire/ -- The report "Diuretic Drugs Market by Product Type and Geography - Forecast and Analysis 2022-2026" has been added to Technavio's offerings. The market size is anticipated to grow by USD 95.64 million from 2021 to 2026. In addition, the growth momentum of the market will accelerate at a CAGR of 5.44% during the forecast period.
Technavio provides a comprehensive report summary describing the market size and forecast along with research methodology. The FREE sample report is available in PDF format
Market Drivers
The increasing incidence of hypertension due to the increasing pressure on the walls of the arteries is driving the growth of the market. Hypertension raises the risk of diseases such as kidney failure, stroke, and heart disease. It can also affect the brain by causing a stroke, TIA, dementia, or mild cognitive impairment. The prevalence of hypertension in low- and middle-income countries is high. Hypertension has no warning signs or symptoms. Hence, it is also known as the silent killer. It can also cause bone loss, sexual dysfunction, and conditions such as obstructive sleep apnea (OSA). Thus, the rise in the number of patients with hypertension owing to obesity, diabetes, CKD, stress, sedentary lifestyle, and alcohol addiction will drive the growth of the market during the forecast period.
Vendor Landscape
The diuretic drugs market is concentrated, and the vendors are deploying growth strategies such as investments in R&D to compete in the market. The competition among vendors is high owing to the fast-growing sales of some of the diuretic drugs. In addition, a strong pipeline of drugs to treat high blood pressure and edema will intensify the competition further during the forecast period. The market will record the approvals for several promising drugs, which will intensify competition among vendors.
Company Profiles
The diuretic drugs market report includes information on the product launches, sustainability, and prospects of leading vendors including AbbVie Inc., Akorn Inc., Alembic Pharmaceuticals Ltd., Amneal Pharmaceuticals Inc., Aurobindo Pharma Ltd., Bausch Health Companies Inc., Casper Pharma, Hikma Pharmaceuticals Plc, Lannett Co. Inc., Novartis AG, Monarch Pharmachem, Pfizer Inc., Padagis US LLC, Sanofi, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., VITARIS AG, Validus Pharmaceuticals LLC, and Zydus Lifesciences Ltd.
Technavio's reports provide key strategic initiatives used by vendors, along with key news and the latest developments. View our FREE PDF Sample Report Now
Competitive Analysis
The report includes competitive analysis, a proprietary tool to evaluate and analyze the position of companies based on their industry position score and market performance score. The tool uses various factors for categorizing the players into categories such as growth strategies, financial performance over the last three years, new product launches, innovation score, growth in market share, investments, etc.
Market Segmentation
By product type, the market has been classified into loop diuretics, thiazide diuretics, and others. The loop diuretic drugs will contribute the largest share of the market during the forecast period.
By geography, the market has been classified into North America, Europe, Asia, and Rest of World (ROW). North America will have the largest share of the market during the forecast period.
Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a FREE PDF Sample Report
Related Reports
Motion Sickness Drugs Market by Product and Geography - Forecast and Geography 2022-2026: The motion sickness drugs market is projected to grow by USD 119.64 million from 2021 to 2026.
Antihypertensive Drugs Market by Type and Geography - Forecast and Analysis 2022-2026: The antihypertensive drugs market share is expected to increase by USD 5.87 billion from 2021 to 2026.
Diuretic Drugs Market Scope
Report Coverage
Details
Page number
120
Base year
2021
Forecast period
2022-2026
Growth momentum & CAGR
Accelerate at a CAGR of 5.44%
Market growth 2022-2026
USD 95.64 million
Market structure
Concentrated
YoY growth (%)
4.29
Regional analysis
North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution
North America at 37%
Key consumer countries
US, Canada, Denmark, China, and India
Competitive landscape
Leading companies, competitive strategies, consumer engagement scope
Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, and market condition analysis for the forecast period.
Customization purview
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
Exhibit 128: Validation techniques employed for market sizing
Exhibit 129: Information sources
11.5 List of abbreviations
Exhibit 130: List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Remedium Healthcare Products is proud to announce the launch of NuVeria Labs' revolutionary Sacral Silicone Dressing, now available for purchase on Amazon, bringing advanced wound care solutions directly to consumers' doorsteps.
Designed to address...
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards.
"This product, along with our other innovations,...
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...